STOCK TITAN

Syneos Health to Present at the 2022 Baird Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Syneos Health (Nasdaq:SYNH) will be represented by CEO Michelle Keefe and CFO Jason Meggs at the 2022 Baird Global Healthcare Conference on September 13, 2022, at 2:00 p.m. ET. A webcast of their presentation, including materials and a replay, will be available on the Company’s Investor Relations website.

Positive
  • None.
Negative
  • None.

MORRISVILLE, N.C, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer Michelle Keefe and Chief Financial Officer Jason Meggs are scheduled to present at the 2022 Baird Global Healthcare Conference on September 13, 2022, at 2:00 p.m. ET.

A webcast of the event, along with a link to the presentation materials and archived replay of the presentation, will be available on the Company’s Investor Relations website at investor.syneoshealth.com.

About Syneos Health
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success. We lead with a product development mindset, strategically blending clinical development, medical affairs and commercial capabilities to address modern market realities.

We bring together more than 29,000 minds, across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients.

Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.

To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.


Investor Relations Contact:Press/Media Contact:
Ronnie SpeightGary Gatyas
Senior Vice President, Investor RelationsExecutive Director, External Communications
+1 919 745 2745+1 908 763 3428
Investor.Relations@syneoshealth.com gary.gatyas@syneoshealth.com


FAQ

When is Syneos Health's presentation at the Baird Global Healthcare Conference?

Syneos Health's presentation at the Baird Global Healthcare Conference is scheduled for September 13, 2022, at 2:00 p.m. ET.

Who will represent Syneos Health at the 2022 Baird Global Healthcare Conference?

CEO Michelle Keefe and CFO Jason Meggs will represent Syneos Health at the conference.

Where can I watch the Syneos Health presentation from the Baird Global Healthcare Conference?

You can watch the webcast of the Syneos Health presentation on their Investor Relations website.

What is Syneos Health's stock symbol?

Syneos Health's stock symbol is SYNH.

What is the purpose of Syneos Health's presentation at the conference?

The presentation aims to discuss Syneos Health's integrated biopharmaceutical solutions and customer success strategies.

Syneos Health, Inc.

NASDAQ:SYNH

SYNH Rankings

SYNH Latest News

SYNH Stock Data

4.46B
103.15M
0.49%
94.75%
6.52%
Diagnostics & Research
Healthcare
Link
United States
Morrisville